Viatris Inc. is recalling 3,931 cartons of Mylan Ampicillin for Injection, USP (ampicillin), an injectable antibiotic medication. The recall was issued after a single strand of hair was discovered inside one of the medication vials. These products were distributed nationwide throughout the United States.
Injecting a drug contaminated with foreign material such as hair can cause local irritation, inflammation, or serious systemic complications if the material travels through the bloodstream. While one complaint has been received, no injuries or illnesses have been reported to date.
Recall #: D-1542-2022; Mylan Manufactured in India for: Mylan Institutional LLC
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.